BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19258055)

  • 1. Protein arrays as tools for serum autoantibody marker discovery in cancer.
    Kijanka G; Murphy D
    J Proteomics; 2009 Aug; 72(6):936-44. PubMed ID: 19258055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays.
    Murphy MA; O'Connell DJ; O'Kane SL; O'Brien JK; O'Toole S; Martin C; Sheils O; O'Leary JJ; Cahill DJ
    J Proteomics; 2012 Aug; 75(15):4668-75. PubMed ID: 22415278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in cancer: prognostic biomarkers and immune activation.
    Järås K; Anderson K
    Expert Rev Proteomics; 2011 Oct; 8(5):577-89. PubMed ID: 21999829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated antigen arrays for the serological diagnosis of cancer.
    Casiano CA; Mediavilla-Varela M; Tan EM
    Mol Cell Proteomics; 2006 Oct; 5(10):1745-59. PubMed ID: 16733262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays.
    Gupta S; Manubhai KP; Mukherjee S; Srivastava S
    Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
    Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral response to cancer as a tool for biomarker discovery.
    Desmetz C; Cortijo C; Mangé A; Solassol J
    J Proteomics; 2009 Aug; 72(6):982-8. PubMed ID: 19539066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
    Chatterjee M; Draghici S; Tainsky MA
    Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to tumor-associated antigens as cancer biomarkers.
    Belousov PV; Kuprash DV; Nedospasov SA; Shebzukhov YV
    Curr Mol Med; 2010 Mar; 10(2):115-22. PubMed ID: 20196734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying autoantibody signatures in cancer: a promising challenge.
    Desmetz C; Maudelonde T; Mangé A; Solassol J
    Expert Rev Proteomics; 2009 Aug; 6(4):377-86. PubMed ID: 19681673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses.
    Cekaite L; Hovig E; Sioud M
    Methods Mol Biol; 2007; 360():335-48. PubMed ID: 17172738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
    Draghici S; Chatterjee M; Tainsky MA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum autoantibodies as biomarkers for early cancer detection.
    Tan HT; Low J; Lim SG; Chung MC
    FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput.
    Chatterjee M; Wojciechowski J; Tainsky MA
    Methods Mol Biol; 2009; 520():21-38. PubMed ID: 19381945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen arrays for profiling autoantibody repertoires.
    Ayoglu B; Schwenk JM; Nilsson P
    Bioanalysis; 2016 May; 8(10):1105-26. PubMed ID: 27097564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.
    Beeton-Kempen N; Duarte J; Shoko A; Serufuri JM; John T; Cebon J; Blackburn J
    Int J Cancer; 2014 Oct; 135(8):1842-51. PubMed ID: 24604332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
    Lu H; Goodell V; Disis ML
    J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays.
    Gunawardana CG; Memari N; Diamandis EP
    Clin Biochem; 2009 Mar; 42(4-5):426-9. PubMed ID: 19094976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of autoantibody signatures for common cancers.
    Kobayashi M; Katayama H; Fahrmann JF; Hanash SM
    Semin Immunol; 2020 Feb; 47():101388. PubMed ID: 31924500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.